col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

142 Results       Page 1

Elsevier: European Journal of Cancer
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 COVID-19 and the impact of the social determinants of health on health-related outcomes in women with breast cancer: a prospective cohort study C. Myers
2 [GO] 2024―Mar―22 Lessons learned from COVID-19: improving breast cancer services from the patient perspective C. Myers, K. Bennett, C. Cahir
3 [GO] 2024―Mar―22 SARS-CoV-2 M-protein promotes malignancy of breast cancer cells and alters interaction in breast tumor microenvironment T.H.N. Nguyen, M. Usuda, S. Park, C.K. Vuong, T. Yamashita, O. Ohneda
4 [GO] 2024―Feb―05 Effectiveness and safety of COVID-19 vaccination in people with blood cancer Emma Copland, Jennifer Hirst, Emma Mi, Martina Patone, Daniel Chen, Carol Coupland, Julia Hippisley-Cox
5 [GO] 2023―Sep―20 The impact of COVID-19 on anxiety, depression, and delays in care for patients with mycosis fungoides Ananya Munjal, Olivia Pierog, David Weiner, Sai Talluru, Austin Burns, Sima Rozati
6 [GO] 2023―Apr―30 Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis Atsunori Baba, Takuya Tokunaga, Koichi Sakasegawa, Takuro Kanekura, Hirohito Tsubouchi
7 [GO] 2023―Feb―10 Uptake of COVID-19 vaccination in people with blood cancer: population-level cohort study of 12 million patients in England Jennifer Hirst, Emma Mi, Emma Copland, Martina Patone, Carol Coupland, Julia Hippisley-Cox
8 [GO] 2023―Feb―09 Refusal of vaccination against influenza and COVID-19 in patients with solid cancers: from bio-ethical issues to solutions Henri-Corto Stoeklé, Sakina Sekkate, Alexandre Vallée, Philippe Beuzeboc, Christian Hervé
9 [GO] 2022―Dec―10 AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants Nicola Giesen, Elena Busch, Enrico Schalk, Gernot Beutel, Maria M. Rüthrich, Marcus Hentrich, et al. (+21)
10 [GO] 2022―Nov―18 COVID-19, breast cancer care, and social determinants of health: a cross-sectional study to investigate the impact of a pandemic on health and health care C. Myers, C. Cahir, K. Bennett
11 [GO] 2022―Nov―18 Quality of Life of breast cancer patients with COVID-19 disease J.I. Arraras, J.J. Illarramendi, A. Manterola-Burgaleta, S. de la Cruz, U. Zarandona, B. Ibañez, et al. (+6)
12 [GO] 2022―Nov―18 Oncophone20 study: Patients’ perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers E. Picardo, M.G. Bau’, A. Mondino, A. Surace, F. Gallo, C. Anatrone, et al. (+2)
13 [GO] 2022―Nov―18 Effect of Covid-19 pandemic on breast cancer disease progression A. Butt, A. Hill
14 [GO] 2022―Nov―18 Utility Of Telephone-Based Psychological Support Among Breast Cancer Patients During Covid-19 Pandemic: An Observational Study A. Datta
15 [GO] 2022―Nov―18 Analysis of factors with impact on duration of hospitalisation for patients operated for breast cancer during COVID 19 pandemic Z. Maksimovic, A. Curcic, R. Ljubisavljevic, I. Zarev, I. Simovic, M. Misic, et al. (+14)
16 [GO] 2022―Nov―18 A systematic review on management of breast cancer patients during the covid 19 pandemic: To assess if there was a clinical delay in treatment and patient perception on delayed treatment. Literature review of the current covid 19 management guidelines for breast cancer patients R.N. Shah, B. Patel
17 [GO] 2022―Oct―12 The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA certified breast centers Peter van Dam, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Cynthia Aristei, Laura Biganzoli, et al. (+50)
18 [GO] 2022―Jul―13 COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study Lennard YW. Lee, Maria C. Ionescu, Thomas Starkey, Martin Little, Michael Tilby, Arvind R. Tripathy, et al. (+42)
19 [GO] 2022―Jun―27 Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicenter real-life cohort study Sonia Priou, Guillaume Lamé, Gérard Zalcman, Marie Wislez, Romain Bey, Gilles Chatellier, et al. (+6)
20 [GO] 2022―Jun―03 Booster Doses of COVID-19 Vaccines for Haematological and Solid Cancer Patients: A Systematic Review and Individual Patient Data Meta-Analysis Aaron Shengting Mai, Ainsley Ryan Yan Bin Lee, Ryan Yong Kiat Tay, Lauren Shapiro, Astha Thakkar, Balazs Halmos, et al. (+14)
21 [GO] 2022―May―25 SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines Anna Maria Di Giacomo, Gianluca Giacobini, Gabriele Anichini, Claudia Gandolfo, Vincenzo D’alonzo, Luana Calabrò, et al. (+3)
22 [GO] 2022―May―23 Vaccination against SARS-CoV-2 protects from morbidity, mortality, and sequelae from COVID19 in patients with cancer David J. Pinato, Daniela Ferrante, Juan Aguilar-Company, Mark Bower, Ramon Salazar, Oriol Mirallas, et al. (+45)
23 [GO] 2022―Apr―26 Persistence of long-term COVID-19 sequelae in patients with cancer: an analysis from the OnCovid registry. Alessio Cortellini, Ramon Salazar, Alessandra Gennari, Juan Aguilar-Company, Mark Bower, Alexia Bertuzzi, et al. (+28)
24 [GO] 2022―Apr―20 The National COVID-19 Vaccination Campaign Targeting the Extremely Vulnerable: the Florence Medical Oncology Unit Experience in Patients with Cancer Maria Simona Pino, Simone Cheli, Marco Perna, Valentina Fabbroni, Clara Giordano, Francesca Martella, et al. (+16)
25 [GO] 2022―Mar―18 Clinical profile and mortality of Sars-Cov-2 infection in cancer patients across two pandemic time periods (Feb 2020-Sep 2020; Sep2020- May 2021) in the Veneto Oncology Network: the ROVID study Maria Vittoria Dieci, Giuseppe Azzarello, Vittorina Zagonel, Franco Bassan, Stefania Gori, Giuseppe Aprile, et al. (+19)
26 [GO] 2022―Mar―15 Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients Giorgio Patelli, Arianna Pani, Alessio Amatu, Francesco Scaglione, Andrea Sartore-Bianchi
27 [GO] 2022―Mar―01 Limited T-cell response to mRNA SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments Alfonso Cortés, José Luis Casado, Federico Longo, Juan José Serrano, Cristina Saavedra, Héctor Velasco, et al. (+21)
28 [GO] 2022―Feb―25 SARS-CoV-2 Vaccine in Patients with Thymic Epithelial Tumours with and without active or pre-existing autoimmune disorders: brief report of a TYME Network safety analysis Federica Giugliano, Paolo Andrea Zucali, Giulia Galli, Zelmira Ballatore, Chiara Corti, Pamela Trillo Aliaga, et al. (+13)
29 [GO] 2022―Feb―10 Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients P. Heudel, B. Favier, M.-L. Solodky, S. Assaad, N. Chaumard, O. Tredan, et al. (+11)
30 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: nationwide registration study in Japan. Nobuyuki Horita
31 [GO] 2022―Feb―10 Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: a French comprehensive multicentre ambispective observational cohort study (CAPANCOVID) Mathias Brugel, Léa Letrillart, Camille Evrard, Aurore Thierry, David Tougeron, Mehdi El Amrani, et al. (+22)
32 [GO] 2022―Feb―07 Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study Maximilian J. Mair, Julia M. Berger, Manfred Mitterer, Margaretha Gansterer, Arne C. Bathke, Wolfgang Trutschnig, et al. (+10)
33 [GO] 2022―Feb―01 Parallel Evolution and Differences in Seroprevalence of SARS-CoV-2 Antibody Between Cancer Patients and Health Care Workers in a Tertiary Cancer Center During First and Second Wave of COVID-19 Pandemic: canSEROcov-II Cross Sectional Study Sylvain Ladoire, Emilie Rederstorff, Vincent Goussot, Sophie Parnalland, Nathalie Briot, Elise Ballot, et al. (+25)
34 [GO] 2021―Dec―29 Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer patients Y. Debie, T. Vandamme, M.E. Goossens, P.A. van Dam, M. Peeters
35 [GO] 2021―Dec―22 Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment Alessio Amatu, Arianna Pani, Giorgio Patelli, Oscar Matteo Gagliardi, Marina Loparco, Daniele Piscazzi, et al. (+9)
36 [GO] 2021―Nov―24 Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal CANCERS in The Netherlands Esther Toes-Zoutendijk, Geraldine Vink, Iris D. Nagtegaal, Manon C.W. Spaander, Evelien Dekker, Monique E. van Leerdam, et al. (+3)
37 [GO] 2021―Oct―27 Immunogenicity and Risk of SARS-CoV-2 Infection after COVID-19 Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis Andrea Becerril-Gaitan, Bryan F. Vaca-Cartagena, Ana S. Ferrigno, Fernanda Mesa-Chavez, Tonatiuh Barrientos-Gutiérrez, Marco Tagliamento, et al. (+2)
38 [GO] 2021―Oct―25 Life-prolonging treatment restrictions and outcome in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium K. de Joode, J. Tol, P. Hamberg, M. Cloos, E.A. Kastelijn, J.S.W. Borgers, et al. (+76)
39 [GO] 2021―Oct―25 Evaluation of COVID-19 vaccine response in cancer patients: an interim analysis Son Tran, Tony.H. Truong, Aru Narendran
40 [GO] 2021―Oct―13 Extracorporeal photopheresis during the COVID-19 pandemic: experience in Argentina Jenny Andrea Baquero Rey, Martina Granara, Luis Daniel Mazzuoccolo, Paula Andrea Enz
41 [GO] 2021―Oct―13 Experience of a supra-regional cutaneous lymphoma centre during the COVID-19 pandemic Uyen Nguyen, Kevin Molloy, Shazia Zara Jaulim, Farida Shah, Jinah Yoo, Julia Scarisbrick
42 [GO] 2021―Oct―13 COVID-19 infection in patients with Sézary syndrome: report of three cases Martina Granara, Jenny Andrea Baquero Rey, Luis Daniel Mazzuoccolo, Paula Andrea Enz
43 [GO] 2021―Oct―13 International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19 Larisa J Geskin, Tiffany Garcia-Saleem, Oleg E Akilov, Paula Enz, Emmanuella Guenova, Pablo L Ortiz-Romero, et al. (+7)
44 [GO] 2021―Oct―13 Cutaneous T-cell lymphoma (CTCL) exacerbation after viral vector COVID-19 vaccination Evdoxia Panou, Vasiliki Nikolaou, Stella Kaliampou, Polytimi Sidiropoulou, Alexander Stratigos
45 [GO] 2021―Oct―12 Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care Emanuele Garreffa, Ahmed Hamad, Ciara C. O’Sullivan, Antonious Z. Hazim, Joanne York, Shama Puri, et al. (+3)
46 [GO] 2021―Oct―12 SARS-CoV-2 in Children with Cancer or Following Haematopoietic Stem Cell Transplant: An Analysis of 131 Patients Gabrielle M. Haeusler, Roland A. Ammann, Fabianne Carlesse, Andreas H. Groll, Dina Averbuch, Elio Castagnola, et al. (+9)
47 [GO] 2021―Oct―12 Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment Tania Buttiron Webber, Nicoletta Provinciali, Marco Musso, Martina Ugolini, Monica Boitano, Matteo Clavarezza, et al. (+16)
48 [GO] 2021―Sep―29 Letter to Editor, Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey Cynthia Villarreal-Garza, Bryan F. Vaca-Cartagena, Andrea Becerril-Gaitan, Fernando Castilleja-Leal
49 [GO] 2021―Sep―27 Reply to letter entitled: Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey Vincenzo Di Noia, Federica Riva, Mattia Di Civita, Antonella Cosimati, Francesco Cognetti
50 [GO] 2021―Sep―27 Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey Luigi Cavanna, Chiara Citterio, Evelina Cattadori, Costanza Bosi, Serena Caprioli
51 [GO] 2021―Sep―02 COVID-19 vaccines in adult cancer patients with solid tumors undergoing active treatment: seropositivity and safety. A prospective observational study in Italy Luigi Cavanna, Chiara Citterio, Claudia Biasini, Serena Madaro, Nicoletta Bacchetta, Anna Lis, et al. (+14)
52 [GO] 2021―Aug―26 Re: COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) Kazuki Takada, Shinkichi Takamori, Naoko Miura, Yasunori Shikada, Mototsugu Shimokawa
53 [GO] 2021―Aug―10 Safety and immunogenicity following 2 doses of BNT162b2 COVID-19 vaccine in an early phase oncology trial center population N. Malissen, L. Ninove, Xavier de Lamballerie, N. André, C. Gaudy-Marqueste
54 [GO] 2021―Aug―05 SARS-CoV-2 vaccination and cancer therapy: a successful but mindful mix Anna Maria Di Giacomo, Gianluca Giacobini, Claudia Gandolfo, Maria Fortunata Lofiego, Maria Grazia Cusi, Michele Maio
55 [GO] 2021―Jul―28 COVID-19 mRNA Vaccines and Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors Yu-Wei Chen, Matthew D. Tucker, Kathryn E. Beckermann, Wade T. Iams, Brian I. Rini, Douglas B. Johnson
56 [GO] 2021―Jun―30 COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study) Nicola Fazio, Lorenzo Gervaso, Thorvadur R. Halfdanarson, Anna La Salvia, Johannes Hofland, Jorge Hernando, et al. (+15)
57 [GO] 2021―Jun―26 Covid-19 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up - a monocenter study J.-M. Placke, H. Reis, E. Hadaschik, A. Roesch, D. Schadendorf, I. Stoffels, J. Klode
58 [GO] 2021―Jun―23 BNT162b2 mRNA Covid-19 Vaccine in AYA with cancer: a monocentric experience Gabriel Revon-Riviere, Laetitia Ninove, Victoria Min, Angélique Rome, Carole Coze, Arnauld Verschuur, et al. (+2)
59 [GO] 2021―Jun―18 Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer Jérôme Barrière, Daniel Re, Frédéric Peyrade, Michel Carles
60 [GO] 2021―May―28 Impact of COVID-19 on healthcare organization and cancer outcomes A. Bardet, A.M. Fraslin, J. Marghadi, I. Borget, M. Faron, C. Honoré, et al. (+15)
61 [GO] 2021―May―27 Cancer during the COVID-19 pandemic: did we shout loudly enough and did anyone listen? A lasting legacy for nations Pat Price
62 [GO] 2021―May―26 The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey Vincenzo Di Noia, Davide Renna, Vittoria Barberi, Mattia Dicivita, Federica Riva, Giulia Costantini, et al. (+6)
63 [GO] 2021―May―24 Adherence to COVID-19 Vaccines in Cancer Patients: Promote It and Make It Happen! Giuseppe Curigliano, Alexander M.M. Eggermont
64 [GO] 2021―May―17 Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19 Emre Yekedüz, Güngör Utkan, Yüksel Ürün
65 [GO] 2021―May―15 Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19 Caifeng Zou, Yuting Huang, Yuchi Ma, Feng Yang, Deliang Fu
66 [GO] 2021―May―05 Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: a national population-based modelling study in England, UK. Adrian Gheorghe, Camille Maringe, James Spice, Arnie Purushotham, Kalipso Chalkidou, Bernard Rachet, et al. (+2)
67 [GO] 2021―Apr―06 Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study David J. Pinato, Lorenza Scotti, Alessandra Gennari, Emeline Colomba-Blameble, Saoirse Dolly, Angela Loizidou, et al. (+63)
68 [GO] 2021―Apr―02 SARS-CoV-2 vaccination for patients with solid cancer: review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER) David Tougeron, Maxime Hentzien, Barbara Seitz-Polski, Firouze Bani-Sadr, Jean Bourhis, Michel Ducreux, et al. (+18)
69 [GO] 2021―Mar―27 Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients Laura Mansi, Laurie Spehner, Etienne Daguindau, Kevin Bouiller, Hamadi Almotlak, Ulrich Stein, et al. (+13)
70 [GO] 2021―Mar―20 High levels of TNFα in patients with COVID-19 refractory to tocilizumab F.X. Danlos, F. Ackermann, J. Rohmer, M. Roumier, A. Marabelle, J.M. Michot
71 [GO] 2021―Mar―18 Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic Koji Matsuo, Muneaki Shimada, Shinya Matsuzaki, Takayuki Enomoto, Mikio Mikami
72 [GO] 2021―Mar―14 Abscopal anti-tumor effect in a patient with melanoma and COVID-19 Hugo Herrscher, Benoit Sauer, Pierre Truntzer, Caroline Robert
73 [GO] 2021―Feb―27 Seroprevalence of SARs-CoV-2 among the staff and patients of a French cancer centre after first lockdown: the canSEROcov study Sylvain Ladoire, Vincent Goussot, Emilie Redersdorff, Adele Cueff, Elise Ballot, Caroline Truntzer, et al. (+25)
74 [GO] 2021―Feb―27 Immunoglobin G / total antibody testing for SARS-CoV-2: a prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing 3 commercial tests Peter van Dam, Manon Huizing, Ella Roelant, An Hotterbeekx, Fien HR. De Winter, Samir Kumar-Singh, et al. (+11)
75 [GO] 2021―Feb―25 Management of Cancer Patients during the COVID-19 Pandemic: the Italian perspective on the Second Wave Alice Indini, Graziella Pinotti, Fabrizio Artioli, Carlo Aschele, Daniele Bernardi, Alfredo Butera, et al. (+13)
76 [GO] 2021―Feb―25 Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action Chiara Corti, Edoardo Crimini, Paolo Tarantino, Gabriella Pravettoni, Alexander M.M. Eggermont, Suzette Delaloge, Giuseppe Curigliano
77 [GO] 2021―Feb―25 New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of national lockdown Emmanuelle Kempf, Guillaume Lamé, Richard Layese, Sonia Priou, Gilles Chatellier, Hedi Chaieb, et al. (+12)
78 [GO] 2021―Feb―23 Prolonged SARS-CoV-2 viral shedding in patients with solid tumors and associated factors Jacobo Rogado, Pedro Gullón, Berta Obispo, Gloria Serrano, Miguel Ángel Lara
79 [GO] 2021―Feb―19 SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: recommendations from the French society for Immuno-Therapy of Cancer (FITC) Marie-Léa Gauci, Clélia Coutzac, Roch Houot, Aurélien Marabelle, Céleste Lebbé
80 [GO] 2021―Feb―10 2021 Update of the AGIHO guideline on evidence-based management of COVID-19 in cancer patients regarding diagnostics, viral shedding, vaccination and therapy Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, et al. (+12)
81 [GO] 2021―Feb―05 Epidemiology and clinical course of SARS-CoV-2 infection in cancer patients in the Veneto Oncology Network: The ROVID Study Valentina Guarneri, Franco Bassan, Vittorina Zagonel, Michele Milella, Marta Zaninelli, Anna Maria Cattelan, et al. (+23)
82 [GO] 2021―Jan―22 Prevention of healthcare-associated respiratory viral infections amongst oncology inpatients: infection prevention outcomes during COVID-19 pandemic Liang En Wee, Edwin Philip Conceicao, Kennedy Yao-Yi Ng, Chee Kian Tham, Indumathi Venkatachalam
83 [GO] 2020―Dec―25 Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era Víctor Rodriguez-Freixinos, Jaume Capdevila, Marianne Pavel, Alia Thawer, Eric Baudin, Dermot O'Toole, et al. (+11)
84 [GO] 2020―Nov―28 SARS-CoV-2 infections in melanoma patients treated with PD-1-inhibitors- a survey of the German ADOREG melanoma registry. Rose K.C. Moritz, Ralf Gutzmer, Lisa Zimmer, Friedegund Meier, Misbah S. Ahmed, Sabine Sell, et al. (+7)
85 [GO] 2020―Oct―20 Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, Alberto Dalla Volta, Pamela Guglielmini, Paolo Zucali, et al. (+19)
86 [GO] 2020―Oct―09 Impact of COVID-19 in Paediatric Early Phase Cancer Clinical Trials in Europe: A report from the Innovative Therapies for Children with Cancer consortium (ITCC) Alba Rubio-San-Simón, Nicolas André, Maria Giuseppina Cefalo, Isabelle Aerts, Alicia Castañeda, Sarah Benezech, et al. (+31)
87 [GO] 2020―Oct―08 Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19) Astrid Lièvre, Anthony Turpin, Isabelle Ray-Coquard, Karine Le Malicot, Juliette Thariat, Guido Ahle, et al. (+547)
88 [GO] 2020―Oct―07 Dutch Oncology COVID-19 Consortium (DOCC): outcome of COVID-19 in patients with cancer in a nationwide cohort study K. de Joode, D.W. Dumoulin, J. Tol, H.M. Westgeest, L.V. Beerepoot, F.W.P.J. van den Berkmortel, et al. (+76)
89 [GO] 2020―Oct―06 A Systematic Review and Meta-Analysis: The Effect of Active Cancer Treatment on Severity of COVID-19 Emre Yekedüz, Güngör Utkan, Yüksel Ürün
90 [GO] 2020―Oct―05 Effects of cancer screening restart strategies after COVID-19 disruption L. Kregting, S. Kaljouw, L. de Jonge, E.E.L. Jansen, E.F.P. Peterse, E.A.M. Heijnsdijk, et al. (+3)
91 [GO] 2020―Oct―05 Impact of COVID-19 on Breast clinic follow ups - a new way forward? C. Norman, L. Ragad, A. Nagarajakumar, H. Irshad, M. Uhercik, I. Giono, et al. (+3)
92 [GO] 2020―Oct―05 Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care during COVID-19 outbreak in North-Eastern Italy. When the going gets tough, the tough gets going! C. Giacometti, M. Maino, A. Ambrosi, S. Zanovello, M. Beda, M. Mion, et al. (+3)
93 [GO] 2020―Oct―05 The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian Breast Unit A. Fancellu, V. Sanna, C. Piredda, L. Ariu, G.Q. Piana, G. Deiana, et al. (+3)
94 [GO] 2020―Oct―05 The impact of the COVID-19 pandemic on quality of life, physical and psychosocial wellbeing in breast cancer patients - a prospective, multicenter cohort study C. Bargon, M. Batenburg, L. van Stam, D.Mink van der Molen, I. van Dam, F. van der Leij, et al. (+10)
95 [GO] 2020―Oct―05 Effect of the COVID-19 pandemic on use of bone-modifying agents for metastatic breast cancer in a UK Oncology centre L. Wang, B. Sribaskaran, M. Ibrahim, M. Karim, A. Neal
96 [GO] 2020―Oct―05 Effects of COVID-19 pandemics in a Breast unit G. Kiziltan, C.B.K. Tumer, C. Ozaslan, O.C. Guler
97 [GO] 2020―Oct―05 Breast referral management and outcome during COVID 19 Pandemic - A UK experience L. Noor, S. Horn, H. Shin, E.J. Turner
98 [GO] 2020―Sep―29 Effect of delay in surgical therapy for early-stage cervical cancer: An implication in the coronavirus pandemic Koji Matsuo, Yongmei Huang, Shinya Matsuzaki, Maximilian Klar, Jason D. Wright
99 [GO] 2020―Sep―22 Repurposing Anticancer Drugs for the Management of COVID-19 Khalid El Bairi, Dario Trapani, Angelica Petrillo, Cécile Le Page, Hanaa Zbakh, Bruno Daniele, et al. (+3)
100 [GO] 2020―Sep―21 Evidence-based Management of COVID-19 in Cancer Patients - Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO) Nicola Giesen, Rosanne Sprute, Maria Rüthrich, Yascha Khodamoradi, Sibylle C. Mellinghoff, Gernot Beutel, et al. (+12)
101 [GO] 2020―Sep―07 Immunological features of coronavirus disease 2019 in patients with cancer Marion Thibaudin, Jean-David Fumet, Marjorie Bon, Léa Hampe, Emeric Limagne, Francois Ghiringhelli
102 [GO] 2020―Sep―06 Risk of death of cancer patients presenting with severe symptoms of infection, with or without documented COVID-19 Souad Assaad, Christine Fuhrmann, Virginie Avrillon, Isabelle Ray-Coquard, Jean-Yves Blay
103 [GO] 2020―Sep―06 Letter of response to comments on: Developing a risk assessment score for cancer patients during COVID-19 pandemic: a war on two fronts. Alice Indini, Erika Rijavec, Michele Ghidini, Monica Cattaneo, Francesco Grossi
104 [GO] 2020―Sep―06 Comment on: Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic Francisco Bautista, Alba Rubio, Jaime Verdú, Anouk Neven, Teresa de Rojas
105 [GO] 2020―Sep―03 High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study Arielle Elkrief, Antoine Desilets, Neha Papneja, Lena Cvetkovic, Catherine Groleau, Yahia Abdelali Lakehal, et al. (+17)
106 [GO] 2020―Sep―02 Mortality in patients with cancer and COVID-19: A systematic review and pooled analysis of 52 studies Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, Richard McNally, Marco Romano, Manuela Leone, et al. (+2)
107 [GO] 2020―Aug―11 Favourable outcome of COVID-19 in an ALK-positive NSCLC patient receiving Alectinib Michele Montrone, Annamaria Catino, Vincenzo Ostilio Palmieri, Vito Longo, Domenico Galetta
108 [GO] 2020―Aug―10 High mortality of cancer patients in times of SARS-Cov-2: do not generalize! Peter A. van Dam, Manon Huizing, Kostantinos Papadimitriou, Hans Prenen, Marc Peeters
109 [GO] 2020―Jul―27 COVID-19 outbreak and Phase 1 trials: should we consider a specific patient management? Sophie Postel-Vinay, Christophe Massard, Jean-Charles Soria
110 [GO] 2020―Jul―09 COVID-19, palliative care and public health Gary Rodin, Camilla Zimmermann, Danielle Rodin, Ahmed al-Awamer, Richard Sullivan, Charlotte Chamberlain
111 [GO] 2020―Jul―07 Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer Vasileios Angelis, Zayd Tippu, Kroopa Joshi, Sara Reis, Firza Gronthoud, Charlotte Fribbens, et al. (+14)
112 [GO] 2020―Jul―04 High dose chemotherapy in a patient with COVID-19 Ugo De Giorgi, Chiara Casadei, Giuseppe Bronte, Mattia Altini, Giovani Martinelli
113 [GO] 2020―Jul―04 Impact of the COVID-19 pandemic on cancer treatment: the patients’ perspective K. de Joode, D.W. Dumoulin, V. Engelen, H.J. Bloemendal, M. Verheij, H.W.M. van Laarhoven, et al. (+3)
114 [GO] 2020―Jul―03 Innovative countermeasures can maintain cancer care continuity during the COVID-19 pandemic in Korea S. Lee, A.-R. Lim, M.-J. Kim, Y. Ji Choi, J.W. Kim, K.H. Park, et al. (+2)
115 [GO] 2020―Jun―25 Could anti-CD20 therapy jeopardize the efficacy of a SARS-CoV-2 vaccine? Roch Houot, Ronald Levy, Guillaume Cartron, Philippe Armand
116 [GO] 2020―Jun―17 Immune-related pneumonitis with nivolumab and ipilimumab during the COVID-19 pandemic Ive Lima Souza, Ítalo Fernandes, Patrícia Taranto, Antonio Carlos Buzaid, Gustavo Schvartsman
117 [GO] 2020―Jun―11 Organizational challenges, volumes of oncological activity, and patients' perception during the SARS-CoV-2 epidemic Serena Zuliani, Ilaria Zampiva, Daniela Tregnago, Miriam Casali, Alessandro Cavaliere, Arianna Fumagalli, et al. (+49)
118 [GO] 2020―Jun―10 Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use? Paul Gougis, Charlotte Fenioux, Christian Funck-Brentano, Marianne Veyri, Joseph Gligorov, Caroline Solas, Jean-Philippe Spano
119 [GO] 2020―Jun―08 A review of the International Early Recommendations for Departments Organization and Cancer Management Priorities during the Global COVID-19 Pandemic. Applicability in Low- and Middle-Income Countries Yazid Belkacemi, Noemie Grellier, Sahar Ghith, Kamel Debbi, Gabriele Coraggio, Adda Bounedjar, et al. (+42)
120 [GO] 2020―Jun―07 High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR Souad Assaad, Virginie Avrillon, Marie-Line Fournier, Benedicte Mastroianni, Bruno Russias, Aurélie Swalduz, et al. (+34)
121 [GO] 2020―Jun―06 Sars-CoV-2 infection in cancer patients undergoing active treatment. Analysis of clinical features and predictive factors for severe respiratory failure and death Ramón Yarza, Mateo Bover, Diana Paredes, Flora López-López, Diego Jara-Casas, Alicia Castelo-Loureiro, et al. (+9)
122 [GO] 2020―Jun―04 Immune checkpoint inhibitors: A physiology-driven approach to the treatment of COVID-19 Serena Di Cosimo, Andrea Malfettone, José Manuel Pérez-García, Antonio Llombart-Cussac, Rosalba Miceli, Giuseppe Curigliano, Javier Cortés
123 [GO] 2020―Jun―04 Cancer treatment during COVID-19 pandemic: do not postpone but decide wisely Olivier Huillard, Francois Goldwasser
124 [GO] 2020―Jun―04 Comment on “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region” and reflections from the Italian Association of Oncology Nurses Valentina Biagioli, Silvia Belloni, Beatrice Albanesi, Alessio Piredda, Rosario Caruso
125 [GO] 2020―Jun―02 Working in the dark: Interaction with a sub clinical COVID-19 subject and lessons learned Shrinivas Rathod, Shahida Ahmed, Robin Vanstone, Tunji Fatoye, Danielle Desautels, Rashmi Koul
126 [GO] 2020―May―31 Developing a risk assessment score for cancer patients during COVID-19 pandemic Alice Indini, Erika Rijavec, Michele Ghidini, Monica Cattaneo, Francesco Grossi
127 [GO] 2020―May―20 Pausing cancer screening during the SARS-CoV-2 pandemic: should we revisit the recommendations? Moran Amit, Samantha Tam, Tarif Bader, Alex Sorkin, Avi Benov
128 [GO] 2020―May―18 Arterial thrombosis and coronavirus disease 2019 in a patient with cancer Rami Nassabein, Bertrand Routy, Normand Blais, Jean-pierre Ayoub, Mustapha Tehfé
129 [GO] 2020―May―18 Risk of coronavirus disease 2019 in patients treated for cancer: An immune response-based hypothesis Michela Roberto, Fabio Basta, Federica Mazzuca, Giuseppe Curigliano, Paolo Marchetti
130 [GO] 2020―May―16 Comment on ‘Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey” by Alice Indini et al. Alberto Bongiovanni, Laura Mercatali, Valentina Fausti, Toni Ibrahim
131 [GO] 2020―May―12 Cancer treatment during COVID-19 pandemic: do not postpone, do it! Claudia Omarini, Michela Maur, Gabriele Luppi, Franco Narni, Mario Luppi, Massimo Dominici, et al. (+2)
132 [GO] 2020―May―03 SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome Anna M. Di Giacomo, Elisabetta Gambale, Santa Monterisi, Monica Valente, Michele Maio
133 [GO] 2020―Apr―29 The experience on COVID-19 and cancer from an oncology hub institution in Milan, Lombardy Region D. Trapani, A. Marra, G. Curigliano
134 [GO] 2020―Apr―27 Patients with cancer in the era of 2019 novel coronavirus disease Koen J. Hartemink, Alexander C.J. van Akkooi, Aletta P.I. Houwink, Emile E. Voest
135 [GO] 2020―Apr―23 COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors Alessandro Leonetti, Francesco Facchinetti, Teresa Zielli, Elena Brianti, Marcello Tiseo
136 [GO] 2020―Apr―20 Lessons from the COVID-19 pandemic - will virtual patient management reshape uro-oncology in Germany? Severin Rodler, Maria Apfelbeck, Christian Stief, Volker Heinemann, Jozefina Casuscelli
137 [GO] 2020―Apr―18 Cancer and COVID-19; how do we manage cancer optimally through a public health crisis? Eduard Vrdoljak, Richard Sullivan, Mark Lawler
138 [GO] 2020―Apr―11 Managing patients with cancer in the COVID-19 era Ling Peng, Sladjana Zagorac, Justin Stebbing
139 [GO] 2020―Apr―07 A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19-positive patients with cancer Florian Scotté, Etienne Minvielle, Olivier Mir, Fabrice André, Fabrice Barlesi, Jean-Charles Soria
140 [GO] 2020―Apr―07 Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment Ondrej Hrusak, Tomas Kalina, Joshua Wolf, Adriana Balduzzi, Massimo Provenzi, Carmelo Rizzari, et al. (+35)
141 [GO] 2020―Apr―06 Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic Paolo Tarantino, Dario Trapani, Giuseppe Curigliano
142 [GO] 2020―Apr―06 Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey Alice Indini, Carlo Aschele, Luigi Cavanna, Mario Clerico, Bruno Daniele, Giammaria Fiorentini, et al. (+9)

142 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec